Radiofrequency during liver surgery to reduce cancer coming back
Part of Cancer, Digestive system clinical trials.
This study looks at whether using radiofrequency (a heat-based treatment used during surgery) during liver surgery can lower the chances that cancer returns locally. It includes people with colorectal cancer that has spread to the liver and people with liver cancer (HCC).
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be willing to sign consent and can stop the study anytime
- You must be 18 years or older
- Your general physical ability should be good (WHO 0–2) and your heart/lung risk score should be ASA 1–3
- You must have liver cancer that can be surgically removed: colorectal cancer spread to the liver (CRLM) confirmed by imaging or biopsy, or liver cancer (HCC)
- You must NOT have other active cancers besides the one related to the liver, with a few minor exceptions
- You cannot be pregnant, cannot have non-removable spread outside the liver, and cannot join another clinical trial
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing whether a procedure called radiofrequency ablation (using heat to destroy tumors) is safe and effective for people whose colorectal cancer has spread to the liver and come back there. It might help if you have a few small liver tumors that cannot be removed with surgery.
This trial tests a treatment to boost the immune system after a procedure called radiofrequency ablation (RFA) that uses heat to destroy liver tumors. It is for people with colorectal cancer that has spread to the liver but not elsewhere, and aims to see if this can improve outcomes.
This trial tests a new type of treatment using low-energy radio waves (called electromagnetic fields) for people with advanced liver cancer that can't be removed by surgery. The goal is to see if adding this therapy can help your immune system fight the cancer better.
This trial looks at whether using a heat-based treatment (RFA) to trigger the immune system before or during liver surgery can improve outcomes for people with colon cancer that has spread to the liver. It’s aimed at people who plan to have the liver tumors removed because they look treatable.
This study compares two ways to treat liver cancer that has come back after surgery: a keyhole operation (laparoscopic surgery) to remove the tumor, or a procedure that uses heat to destroy it (radiofrequency ablation). The goal is to see which approach is better for people with small, limited recurrences.
This trial tests two procedures—irreversible electroporation and stereotactic body radiotherapy—for people whose colorectal cancer has spread to the liver (1–3 tumors near major blood vessels or bile ducts) and can't be surgically removed or treated with heat. The goal is to see if these approaches can safely destroy those hard-to-reach tumors.
Hear when a new Liver Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.